Clinical Trial Update: Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population [NA]

View source ↗

Summary

This clinical trial update describes an ongoing study evaluating intensive lipid-lowering therapy to affect coronary plaque and major adverse cardiovascular eve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Coronary Artery Disease Progression | NA | Status: ENROLLING_BY_INVITATION